BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8833385)

  • 1. Retroperitoneal lymphadenectomy: the traditional treatment option.
    Jewett MA; Incze P
    Semin Urol Oncol; 1996 Feb; 14(1):24-9. PubMed ID: 8833385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance pf retroperitoneal lymphadenectomy in the treatment of disseminated germinogenic testicular tumors after induction chemotherapy].
    Mitin AV; Figurin KM; Matveev BP; Tiuliandin SA; Bukharin BV; Volkova MI; Matveev VB
    Urologiia; 2000; (6):12-6. PubMed ID: 11186312
    [No Abstract]   [Full Text] [Related]  

  • 3. [Testicular tumor--retroperitoneal lymph node excision successful in patients with stage I nonseminomatous cancer with or without vascular invasion].
    Brudermanns B
    Aktuelle Urol; 2007 Jan; 38(1):1-2. PubMed ID: 17290323
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
    J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
    Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic retroperitoneal lymphadenectomy for stage I non-seminomatous testicular tumors.
    Custureri F; Urciuoli P; Iavarone C; D'Orazi V; Gabatel R; Ghinassi S; Patrizi G; Palazzini G; Di Matteo FM; Peparini N
    Hepatogastroenterology; 2005; 52(66):1677-80. PubMed ID: 16334755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma.
    Foster RS; Donohue JP
    J Urol; 2000 Jun; 163(6):1788-92. PubMed ID: 10799183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve sparing retroperitoneal lymphadenectomy in clinical stage I, low stage II and after chemotherapy in stage III nonseminomatous testicular cancer.
    Javadpour N
    Prog Clin Biol Res; 1988; 277():53-62. PubMed ID: 3054910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroperitoneal lymphadenectomy in staging and treatment of clinical stage I and II nonseminomatous testis cancer (NSGCT): the development of nerve-sparing techniques.
    Donohue JP
    Cancer Treat Res; 1996; 88():105-19. PubMed ID: 9239475
    [No Abstract]   [Full Text] [Related]  

  • 11. Laparoscopic retroperitoneal lymphadenectomy after chemotherapy for stage IIB nonseminomatous testicular carcinoma.
    Janetschek G; Hobisch A; Hittmair A; Höltl L; Peschel R; Bartsch G
    J Urol; 1999 Feb; 161(2):477-81. PubMed ID: 9915430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for testicular cancer.
    Xiao H; Sheinfeld J; Motzer RJ
    Surg Oncol Clin N Am; 1997 Oct; 6(4):863-78. PubMed ID: 9309098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery for testicular cancer: indication, results and technical aspects.
    Khouni H; Ghozzi S; Ramzi K; Smaali CH; Majed H; Ben Rais N
    Tunis Med; 2005 Dec; 83 Suppl 12():78-83. PubMed ID: 16430075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical treatment of stage I germ cell tumor of the testis].
    Rubio Briones J; Solsona Narbón E
    Arch Esp Urol; 2000; 53(6):491-9. PubMed ID: 11002517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
    Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
    BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience.
    Steiner H; Peschel R; Janetschek G; Höltl L; Berger AP; Bartsch G; Hobisch A
    Urology; 2004 Mar; 63(3):550-5. PubMed ID: 15028456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical stage I nonseminoma: surgery versus surveillance.
    Foster RS; Roth BJ
    Semin Oncol; 1998 Apr; 25(2):145-53. PubMed ID: 9562447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial.
    Albers P; Siener R; Kliesch S; Weissbach L; Krege S; Sparwasser C; Schulze H; Heidenreich A; de Riese W; Loy V; Bierhoff E; Wittekind C; Fimmers R; Hartmann M;
    J Clin Oncol; 2003 Apr; 21(8):1505-12. PubMed ID: 12697874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of retroperitoneal lymph node dissection in the management of testicular cancer.
    Stephenson AJ; Sheinfeld J
    Urol Oncol; 2004; 22(3):225-33; discussion 234-5. PubMed ID: 15271322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.